GlassScriptPhysician profile
Christopher Jonathan Cole
NPI 1326455221
$363.41
in general payments reported to CMS, 2019-2025
8 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $129 · 2024: $90.49 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $130.44 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Aptima |
| Sumitomo Pharma America, INC. | $71.25 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $51.11 | 2023-2024 | |
| Optumhealth Care Solutions, LLC | $39.69 | 2023-2025 | Zyno Solutions, Vivify Health Care Team Portal, Eitan Medical |
| Exeltis, USA INC. | $24.35 | 2023 | Slynd |
| Daiichi Sankyo INC. | $21.25 | 2024 | Injectafer |
| Amgen INC. | $16.89 | 2025 | Prolia, Evenity |
| Organon LLC | $8.43 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.